| Test | Disease | Scope and Object | Method | Material | Price | Deadline |
|
Inherited Oncological Diseases
|
||||||
| 1 |
Hereditary Breast and Ovarian Cancer (HBOC)
|
Germline mutations in the BRCA1 and BRCA2 genes | Clinical Exome Sequencing, Confirmation by Sanger Sequencing | 5-7 ml. of blood, with EDTA | 850 BGN | 30 working days |
| 2 | Large deletion/insertion rearrangements in the BRCA1 gene | MLPA | 5-7 ml. of blood, with EDTA | 220 BGN | 10 working days | |
| 3 | Large deletion/insertion rearrangements in the BRCA2 gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 10 working days | |
| 4 | Cancer panel of 31 genes associated with HBOC | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 30 working days | |
| 5 |
Hereditary Nonpolyposis Colorectal Cancer HNPCC (Lynch syndrome)
|
Microsatellite instability of a panel of 10 markers (normal sample/tumor) | Fragment Analysis | tumor and normal samples/FFPE/fresh-frozen tissue | 300 BGN | 20 working days |
| 6 | Mutations in 38 colorectal cancer associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 7 | HNPCC (Lynch syndrome) - Mutations in MLH1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 8 | HNPCC (Lynch syndrome) - Mutations in MSH2 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 9 | HNPCC (Lynch syndrome) - Mutations in MSH6 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 230 BGN | 30 working days | |
| 10 | Large deletions/ insertions and rearrangements in MLH1 and MSH2 genes | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days | |
| 11 | A panel of 5 genes associated with HNPCC | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 12 |
Hereditary Gastrointestinal Tumors
|
Mutation in 43 associated genes with hereditary gastrointestinal tumors, colorectal and stomac cancer or polyps developmental risk | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 13 |
Familial adenomatous polyposis (FAP)
|
Mutations in exon 16 of APC gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 280 BGN | 15 working days |
| 14 | Mutations in APC gene (excluding exon 16) | Direct Sequencing | 5-7 ml of blood, with EDTA | 245 BGN | 15 working days | |
| 15 | Mutations in APC gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 480 BGN | 30 working days | |
| 16 | Large deletions/ insertions and rearrangements in APC gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days | |
| 17 |
Hirschsprung's disease
|
Mutations in RET gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days |
| 18 |
Multiple Endocrine Neoplasia (MEN)
|
Mutations in MEN1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 250 BGN | 15 working days |
| 19 | Mutations in exons 10, 11, 13, 14, 15, 16 of RET gene (covering 90% of the known mutations) | Direct Sequencing | 5-7 ml of blood, with EDTA | 160 BGN | 10 working days | |
| 20 | Mutations in all exons of RET gene (excluding exons 10, 11, 13, 14, 15, 16) | Direct Sequencing | 5-7 ml of blood, with EDTA | 240 BGN | 15 working days | |
| 21 | Mutations in RET gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 22 |
Li-Fraumeni syndrome
|
Mutations in TP53 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 250 BGN | 15 working days |
| 23 | Large deletions/ insertions and rearrangements in TP53 gene | MLPA | 5-7 ml of blood, with EDTA or tumor tissue | 220 BGN | 15 working days | |
| 24 |
Familial prostate cancer
|
A panel of 35 genes associated with prostate cancer | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 25 |
Фамилен рак на панкреаса
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с рак на панкреаса | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв / 613.55 EUR | 40 работни дни |
| 26 |
Фамилен рак на кожата
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с рак на кожата | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв / 613.55 EUR | 40 работни дни |
| 27 |
Наследствени онкологични заболявания
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с наследствени онкологични заболявания | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв / 613.55 EUR | 40 работни дни |
| 28 |
Hereditary Paraganglioma / Pheochromocytoma / PGL / PCC syndrome
|
Mutations in 20 genes associated with Hereditary Paraganglioma/ Pheochromocytoma | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 29 |
Hereditary syndromes associated with tumors of the CNS, PNS
|
Mutations in 36 genes associated with CNS/ PNS tumors | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 30 |
RASopathies, Genetic syndromes resulting of mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway
|
Mutations in 36 panel genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 31 |
Hereditary Neuroblastoma
|
Mutation in 2 associated with hereditary neuroblastoma gene panel (ALK and PHOX2B) | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1200 BGN | 40 working days |
| 32 |
Neurofibromatosis type 1
|
Analysis of deep intronic variants | Direct Sequencing | 5-7 ml of blood, with EDTA | 300 BGN | 15 working days |
| 33 | Analysis of the NF1 gene for large deletions / insertions and rearrangements | MLPA | 5-7 ml of blood, with EDTA | 400 BGN | 15 working days | |
| 34 |
Neurofibromatosis type 2
|
Analysis of the NF2 gene for large deletions / insertions and rearrangements | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days |
|
Редки синдроми
|
||||||
| 35 |
Gorlin Goltz syndrome
|
Mutations in exons 2, 3, 6, 8, 9, 10, 13, 15 of PTCH1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 220 BGN | 20 working days |
| 36 | Mutations in exons 1, 4, 5, 7, 11, 12, 14, 16, 17, 18, 19, 20, 21 22, 23 of PTCH1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 280 BGN | 20 working days | |
| 37 | Mutations in PTCH1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 450 BGN | 30 working days | |
| 38 |
Туберозна склероза
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с туберозна склероза | Clinical Exome Sequencing | 5-7 мл. кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
|
Neurological Epilepsy
|
||||||
| 39 |
Epilepsy with febrile seizures, GEFS + and Dravet syndrome
|
Mutations in SCN1A gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 460 BGN | 30 working days |
| 40 | Deletions/duplications and rearrangements of SCN1A gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days | |
| 41 | Mutations, deletions/duplications and rearrangements in SCN1A gene | Direct Sequencing, MLPA | 5-7 ml of blood, with EDTA | 630 BGN | 30 working days | |
| 42 |
Epilepsy with benign neonatal and neonatal-infantile seizures and early onset epileptic encephalopathy
|
Mutations in KCNQ2 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 320 BGN | 30 working days |
| 43 | Deletions/duplications and rearrangements of KCNQ2 gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days | |
| 44 | Mutations, deletions/duplications and rearrangements of KCNQ2 gene | Direct Sequencing, MLPA | 5-7 ml of blood, with EDTA | 500 BGN | 30 working days | |
| 45 |
Childhood absence epilepsy and GLUT1 deficiency
|
Mutations in SLC2A1(GLUT1) gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 240 BGN | 30 working days |
| 46 | Deletions/duplications and rearrangements in SLC2A1(GLUT1) gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 30 working days | |
| 47 | Mutations and deletions/duplications and rearrangements in SLC2A1(GLUT1) gene | Direct Sequencing, MLPA | 5-7 ml of blood, with EDTA | 420 BGN | 30 working days | |
| 48 |
Epileptic encephalopathies
|
Mutations in 516 epileptic encephalopathies associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 49 |
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
|
Mutation in 84 autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) genes | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1200 BGN | 40 working days |
| 50 |
Epilepsy and epileptic syndromes - extended panel
|
Mutations in 1089 epilepsy and epileptic syndromes associated genes | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1600 BGN | 50 working days |
| 51 |
Мigraine
|
Mutations in 24 nuclear encoded genes | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1200 BGN | 40 working days |
| 52 |
Neuromuscular diseases
|
Mutations in 496 neuromuscular disease associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 53 |
Congenital hypotension
|
Mutations in 2981 genes, associated with genetic diseases of the CNS and peripheral neuropathies in childhood | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 54 |
Hereditary spastic paraplegia
|
Mutations in SPG4 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days |
| 55 | Mutations in 111 hereditary spastic paraplegia associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 56 |
Hereditary spastic paraplegia, a recessive form associated with cerebellar ataxia
|
Hotspot mutation p.L78X in SPG7 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 90 BGN | 10 working days |
| 57 |
Hereditary Motor-Sensory Neuropathies
|
Mutations in 281 genes associated with hereditary motor and sensory neuropathies | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 58 |
Hereditary Ataxias
|
Mutations in 661 genes associated with ataxia and syndromes and diseases, which include symptoms of ataxia | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 59 |
Cerebellar hypoplasia
|
Mutations in 68 cerebellar hypoplasia associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
|
Невропсихично развитие
|
||||||
| 60 |
Syndromic intellectual deficit and neurodevelopmental disorders
|
Mutations in 3123 genes associated with intellectual deficit and neuropsychiatric retardation | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1600 BGN | 50 working days |
| 61 |
Autism
|
Mutations in 1131 autistic associated genes | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1600 BGN | 50 working days |
| 62 |
Изоставане в НПР, интелектуален дефицит и/или вродени аномалии
|
Субтеломерни микроделеции/микродупликации, свързани с изоставане в умственото развитие | MLPA | 5-7 мл кръв, с EDTA | 250 лв / 127.82 EUR | 15 работни дни |
| 63 |
Известни микроделеционни/ микродупликационни синдроми
|
Големи делеции/инсерции пренареждания в целия геном, свързани с известни микроделеционни/микродупликационни синдроми | MLPA | 5-7 мл кръв, с EDTA | 250 лв / 127.82 EUR | 15 работни дни |
|
Neurodegenerative Diseases
|
||||||
| 64 |
Alzheimer's disease
|
APOE E2/E3/E4 allele genotyping | Direct Sequencing | 5-7 ml of blood, with EDTA | 90 BGN | 15 working days |
| 65 | A panel of 40 genes associated with AD | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 66 |
Parkinson's disease
|
A panel of 86 genes associated with PD | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 67 |
Dementia
|
A panel of 47 dementia associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 68 |
Frontotemporal degeneration
|
A panel of 23 genes associated with FTD | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 69 |
Amyotrophic lateral sclerosis
|
A panel of 82 genes associated with ALS | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 70 |
Amyotrophic lateral sclerosis/ Frontotemporal degeneration
|
Copy number varioations in C9orf72 | Fragment Analysis | 5-7 ml of blood, with EDTA | 80 BGN | 20 working days |
| 71 |
Motor disorders
|
Mutations in 1360 genes associated with chorea, dystonia and other movement disorders | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 72 |
Leukodystrophy with childhood-onset
|
Mutations in 2938 genes associated with childhood onset leukodystrophy | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 73 |
Leukodystrophy with brain calcifications
|
Mutations in 232 genes associated with leukodystrophy with brain calcifications | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 74 |
Leukodystrophy with late-onset
|
Mutations in 84 genes associated with late-onset leukodystrophy | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
|
Ocular Diseases
|
||||||
| 75 |
Macular degeneration
|
Mutations in ABCA4 gene- coding and non-coding regions | Direct Sequencing | 5-7 ml of blood, with EDTA | 650 BGN | 30 working days |
| 76 | Large deletions/insertions in the ABCA4 gene | MLPA | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 77 | Mutations in a panel of 14 genes associated with Stargardt disease | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 78 | Mutations in BEST1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 200 BGN | 10 working days | |
| 79 | Mutations in a panel of 30 genes associated with macular degeneration | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 80 |
Glaucoma
|
Mutations in CYP1B1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 260 BGN | 30 working days |
| 81 | Mutation p.R299X in LTBP2 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 90 BGN | 10 working days | |
| 82 | Mutations in MYOC gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 130 BGN | 10 working days | |
| 83 | Mutations in 25 genes associated with glaucoma | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 84 |
Cone-rod retinal degeneration
|
Mutations in CRX and GUCY2D genes and exon 15 in RPGR-ORF15 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 450 BGN | 30 working days |
| 85 | Mutations in ABCA4 gene – coding and non-coding regions | Direct Sequencing | 5-7 ml of blood, with EDTA | 650 BGN | 30 working days | |
| 86 | Large deletions/insertions in the ABCA4 gene | MLPA | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 87 | Mutations in 42 genes, associated with cone-rod retinal degeneration | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 88 |
Leber hereditary optic neuropathy
|
Mutations in RPE65 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 230 BGN | 10 working days |
| 89 | Mutations in CRX, IMPDH1 и OTX2 genes | Direct Sequencing | 5-7 ml of blood, with EDTA | 450 BGN | 30 working days | |
| 90 | Mutations in 26, associated with Leber congenital amaurosis | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 91 | Mutations in 3 mitochondrial genes- MT-ND1, MT-ND4 и MT-ND6 | Direct Sequencing | 5-7 ml of blood, with EDTA | 200 BGN | 10 working days | |
| 92 |
Retinal pigment degeneration
|
Mutations in RHO, PRPH2/RDS, PRPF31 and IMPDH1 genes and exon 15 in RPGR-ORF15 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 590 BGN | 30 working days |
| 93 | Mutations in USH2A, CRB1 и RHO genes and exon 15 in RPGR-ORF15 gene | Direct Sequencing | 5-7 ml. of blood, with EDTA | 900 BGN | 40 working days | |
| 94 | exon 15 in RPGR-ORF15 gene | Direct Sequencing | 5-7 ml. of blood, with EDTA | 90 BGN | 20 working days | |
| 95 | Mutations in RPE65 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 230 BGN | 10 working days | |
| 96 | Mutations in BEST1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 200 BGN | 10 working days | |
| 97 | Large deletions/insertions in the RHO, IMPDH1, RP1 and PRPF31 genes | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 30 working days | |
| 98 | Large deletions/insertions in the USH2A | MLPA | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 99 | Large deletions/insertions in EYS gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 30 working days | |
| 100 | Mutations in 341 genes, associated with Retinitis pigmentosa | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days | |
| 101 |
Usher syndrome type 2
|
Mutations in 341 genes assotiated with retinal degeneration | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 102 | Mutations in USH2A gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 880 BGN | 40 working days | |
| 103 | Large insertions/deletions in USH2A gene | MLPA | 5-7 ml of blood, with EDTA | 350 BGN | 30 working days | |
| 104 |
Bardet-Biedl syndrome
|
Mutations in 27 genes associated with Bardet-Biedl syndrome | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 50 working days |
| 105 |
Congenital stationary night blindness
|
Mutations in 14 genes associated with Congenital stationary night blindness | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 50 working days |
| 106 |
Retinoschisis
|
Mutations in RS1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 110 BGN | 10 working days |
| 107 |
Retinoblastoma
|
Mutations in RB1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 325 BGN | 20 working days |
| 108 | Hot-spot mutations in RB1 gene (exons 8,10,11,14,15,17,18,23) | Direct Sequencing | 5-7 ml of blood, with EDTA | 190 BGN | 15 working days | |
| 109 |
Cataract
|
Mutations in 90 genes associated with cataract | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
|
Ear Diseases
|
||||||
| 110 |
Hereditary and sporadic nonsyndromic neurosensory hearing loss
|
Mutations in GJB2(Cx26) gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 120 BGN | 10 working days |
| 111 | Mutations in GJB3 (Cx31) gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 120 BGN | 10 working days | |
| 112 | Mutations in 4 mitochondrial genes- MT-RNR1, MT-TS1 , MT-TL1 , MT-TK | Direct Sequencing | 5-7 ml of blood, with EDTA | 160 BGN | 30 working days | |
| 113 | Mutations in 594 genes associated with hearing loss | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days | |
| 114 |
Sensorineural hearing loss and Wolfram syndrome type 1
|
Large deletions and duplications in GJB2, GJB3, GJB6, WFS1, POU3F4 and detection of 6 mutations in GJB2 гена (c.313del14, c.235delC, c.167delT, c.101T>C, c.35delG и IVS1+1G>A) | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 30 working days |
|
Kidney Diseases
|
||||||
| 115 |
Cortico-resistant nephrotic syndrome
|
Screening for mutations in the coding regions of NHPS1 and NPHS2 genes as well as exons 8 and 9 of WT1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 350 BGN | 10 working days |
| 116 | mutations in 26 genes associated with nephrotic syndrome | Other | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 117 |
Congenital anomalies of the urinary system
|
Screening for mutations in the coding regions of HNF1B and PAX2 genes | Direct Sequencing | 5-7 ml of blood, with EDTA | 280 BGN | 30 working days |
| 118 | Screening for mutations in the coding regions of 214 CAKUT associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days | |
| 119 | Screening for large deletions/duplications affecting the HNF1B gene | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 30 working days | |
| 120 |
UMOD-associated nephropathy
|
Screening for mutations in the coding regions of UMOD gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 265 BGN | 30 working days |
| 121 |
Ciliopathies
|
Mutation panel 250 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 122 |
Наследствени бъбречни заболявания
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с наследствени бъбречни заболявания | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1400 лв. / 715.81 EUR | 50 работни дни |
|
Endocrinological and Liver Diseases
|
||||||
| 123 |
Endocrine diseases
|
Mutations in 810 genes associated with endocrine diseases | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 124 |
Congenital hypopituitarism
|
Mutations in 10 genes associated with pituitary gland diseases | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 125 |
Congenital hypothyroidism
|
Mutations in 24 genes associated with thyroid gland diseases | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 126 | Mutations in TPO gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 280 BGN | 30 working days | |
| 127 | Large deletions/ insertions and rearrangements in TPO, PAX8, FOXE1, NKX2-1 и TSHR genes | MLPA | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days | |
| 128 |
Isolated growth hormone deficiency
|
Mutations in GH1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 130 BGN | 30 working days |
| 129 | Mutations in 10 genes associated with IGHD | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days | |
| 130 |
Maturity-onset diabetes of the young (MODY)
|
Large deletions/ insertions and rearrangements in HNF4A, GCK, HNF1A and HNF1B genes | MLPA | 5-7 ml blood, with EDTA | 220 BGN | 15 working days |
| 131 | Mutations in HNF1B gene | Direct Sequencing | 5-7 ml blood, with EDTA | 190 BGN | 30 working days | |
| 132 | Mutatins in 15 genes associated with MODY | Clinical Exome Sequencing | 5-7 ml blood, with EDTA | 1200 BGN | 40 working days | |
|
Cardiovascular Diseases
|
||||||
| 133 |
Кардиомиопатии и аритмии
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с кардиомиопатии и аритмии | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1600 лв. / 818.07 EUR | 50 работни дни |
| 134 |
Фамилна хиперхолестеролемия
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с фамилна хиперхолестеролемия | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 135 |
Фамилна хипертриглицеридемия
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с фамилна хипертриглицеридемия | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 136 |
Фамилна липодистрофия
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с фамилна липодистрофия | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 137 |
Фамилни заболявания с повишен риск за церебноваскуларен инцидент (инсулт)
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с Фамилни заболявания с повишен риск за церебноваскуларен инцидент (инсулт) | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 138 |
Синдром на Ehler Danlos и свързани заболявания
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани със Синдром на Ehler Danlos и свързани заболявания | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 139 |
Фамилна хемораична телангиектазия и васкуларни малформации
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с фамилна хемораична телангиектазия и васкуларни малформации | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 140 |
Фамилни сърдечни заболявания
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с фамилна изолирано или синдромно вродено сърдечно заболяване | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
|
Mitochondrial and Metabolic Diseases
|
||||||
| 141 |
Mitochondrial diseases
|
Mutations in 37 mitochondial genes associated with mitochondrial diseases | Direct Sequencing | 5-7 ml of blood, with EDTA | 630 BGN | 30 working days |
| 142 | Mutations in 266 nuclear genes associated with mitochondrial diseases | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days | |
| 143 | Големи делеции/инсерции пренареждания в митохондриалната ДНК | MLPA | 5-7 мл кръв, с EDTA | 250 лв. / 127.82 EUR | 20 работни дни | |
|
Connective Tissue Diseases
|
||||||
| 144 |
Connective tissue diseases
|
Mutations in panel of 224 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 145 |
Marfan syndrome and Marfan-like diseases
|
Mutations in panel of 113 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
| 146 | Големи делеции/инсерции пренареждания в FBN1 генa | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 250 лв. / 127.82 EUR | 15 работни дни | |
| 147 |
Skeletal dysplasias
|
Mutations in panel of 597 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 148 |
Мулти малформативни заболявания
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с мулти малформативни заболявания | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1600 лв. / 818.07 EUR | 50 работни дни |
| 149 |
Arthrogryposis
|
Mutations in 288 arthrogryposis associated genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
|
Гастроинтестинални
|
||||||
| 150 |
Моногенни възпалителни заболявания на червата ( IBD) с ранно начало (преди 6 г.възраст).
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с IBD с ранно начало | Direct Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 151 |
Фамилен панкреатит
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с Фамилен панкреатит | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
| 152 |
Болест на Hirschsprung
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с Болест на Hirschsprung | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни |
|
Liver
|
||||||
| 153 |
Liver diseases
|
Mutations in panel ot 204 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
|
Immune system
|
||||||
| 154 |
Immune diseases
|
Mutations in panel of 801 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
|
Метаболитни заболявания
|
||||||
| 157 |
Metabolic diseases
|
Mutations in panel of 1012 genes | Clinical Exome Sequencing | 5-7 ml of blood, wih EDTA | 1600 BGN | 50 working days |
|
Hematological Diseases
|
||||||
| 155 |
Hematological diseases
|
Mutation is panel of 456 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
|
Дерматологични
|
||||||
| 156 |
Syndromic and non-syndromic diseases with dermatological symptoms
|
Mutations in panel of 423 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
|
Others
|
||||||
| 158 |
Reproductive panel - women
|
Mutations in panel of 212 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 159 |
Reproductive panel - men
|
Mutations in panel of 209 genes | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 160 |
Скрининг за хетерозиготно носителство на рецесивни заболявания при двойки
|
Цялостно екзомно секвениране (WES) и анализ на панел от гени, асоциирани с рецесивни заболявания | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 2200 лв. / 1124.84 EUR | 50 работни дни |
| 161 |
Carrier Analysis of Variants Associated with Reproductive Disadvantages
|
Variants in BMP15 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 100 BGN | 15 working days |
| 162 | Variants rs6165 and rs6166 in exon 10 of FSHR gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 100 BGN | 15 working days | |
|
Biomarkers and Individualized Therapy (pharmacogenomics)
|
||||||
| 163 |
BRCA-свързан разширен панел за оценка на фамилен риск и избор на терапия
|
Анализ на BRCA1, BRCA2, CHEK2, PALB2, RAD51C и TP53 гените | Clinical Exome Sequencing | 5-7 мл кръв с EDTA/туморна тъкан | 1100 лв. / 562.42 EUR | 30 работни дни |
| 164 |
Избор на терапия при карцином на гърда
|
Анализ на соматични мутации в ESR1 гена | RT- PCR | туморна тъкан/FFPE/течна биопсия | 300 лв. / 153.39 EUR | 30 работни дни |
| 165 | Анализ на соматични PIK3CA hot-spot мутации | Clinical Exome Sequencing | туморна тъкан/FFPE/течна биопсия | 300 лв. / 153.39 EUR | 30 работни дни | |
| 166 |
Избор на терапия при карцином на простатата
|
Таргетно секвениране на панел от HRR гени за установяване на варианти свързани с дефицит на хомоложна рекомбинация (HRD) | Clinical Exome Sequencing | туморна тъкан/FFPE/течна биопсия | 1450 лв. / 741.37 EUR | 40 работни дни |
| 167 |
Избор на терапия при солидни тумори, свързани с дефицит на хомоложна рекомбинация (рак на гърдата, яйчник, простата и панкреас)
|
Установяване на дефицит на хомоложна рекомбинация (HRD) | Clinical Exome Sequencing | туморна тъкан/FFPE/течна биопсия | 2500 лв. / 1278.23 EUR | 40 работни дни |
| 168 |
Изчерпателно геномно профилиране (CGP) във връзка с избор на терапия при солидни тумори
|
Анализ на соматични ДНК варианти в 517 гена (SNVs, InDels,SVs, CNVs), генни фузии и сплайс варианти на РНК ниво, определяне на дефицит на хомоложна рекомбинация (HRD), (микросателитна нестабилност (MSI), туморен мутационен товар (TMB) | Clinical Exome Sequencing | туморна тъкан/FFPE | 3900 лв. / 1994.04 EUR | 40 работни дни |
| 169 |
Таргетно секвениране на панел от гени при солидни тумори във връзка с избор на терапия
|
Анализ на соматични ДНК варианти (SNVs, InDels,SVs, CNVs) в панел от 95 гени при солидни тумори | Clinical Exome Sequencing | туморна тъкан/FFPE | 1600 лв. / 818.07 EUR | 40 работни дни |
| 170 |
Prognostic markers in tumors of the central nervous system
|
mutaions in exon 4 of IDH1 gene and exon 4 of IDH2 gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 170 BGN | 15 working days |
| 171 | Large deletions/ insertions and rearrangements in chromosome 1p/19q | MLPA | Tumor tissue - FFPE or fresh frozen | 220 BGN | 30 working days | |
| 172 | large deletins/duplications rearrangements PDGFRA, EGFR, CDKN2A, PTEN, CDK4, MIR26A2, MDM2, NFKBIA and TP53 genes | MLPA | Tumor tissue - FFPE or fresh frozen | 220 BGN | 30 working days | |
| 173 |
Diagnostic markers for tumors in the central nervous system, endometrium, stomach, etc.
|
Mutations in ATRX gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 600 BGN | 30 working days |
| 174 | Large deletins/insertions in ATRX gene | MLPA | Tumor tissue - FFPE or fresh frozen | 220 BGN | 30 working days | |
| 175 |
Diagnostic and prognostic markers in brain, PNET, thyroid and other tumors
|
Mutation in promoter region of TERT gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 70 BGN | 30 working days |
| 176 | Mutations in exon 2 of H3F3A gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 70 BGN | 30 working days | |
| 177 | Mutations in exon 1 of HIST1H3B and HIST1H3C genes. | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 110 BGN | 30 working days | |
| 178 |
Diagnostic marker for the presence of DICER1 syndrome
|
Mutations in DICER1 gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 470 BGN | 30 working days |
| 179 |
Diagnostic and Predictive Markers for Targeted Therapy in Gastrointestinal Stromal Tumor (GIST)
|
Mutations in exons 8, 9, 11, 13, 14, 17 and 18 of сKIT gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 195 BGN | 15 working days |
| 180 | Mutations in exons 12, 14 и 18 of PDGFRA gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 130 BGN | 15 working days | |
| 181 | Mutations in exons 9 and 11 of сKIT gene, and mutations in exon 18 of PDGFRA gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 165 BGN | 15 working days | |
| 182 | Mutations in exons 8, 13, 14, 17 and 18 of сKIT gene, exons 12 and 14 of PDGFRA gene and exon 15 of BRAF gene | Direct Sequencing | Tumor tissue - FFPE or fresh frozen | 210 BGN | 15 working days | |
| 183 |
Predictive marker BRAF (V600) mutations for targeted therapy in oncological diseases (melanoma, colorectal and lung carcinomas, thyroid gland, GIST, brain tumors, etc.)
|
Mutations in exon 15 of BRAF gene | Direct Sequencing | 5-7 ml of blood, with EDTA / Tumor tissue - FFPE or fresh frozen | 90 BGN | 15 working days |
| 184 |
Predictive marker for targeted therapy in chronic lymphocytic leukemia/CLL/
|
Mutations in TP53 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 250 BGN | 15 working days |
| 185 | Анализ на TP53 гена, WES | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 40 работни дни | |
| 186 |
Chronic lymphocytic leukemia / CLL / predictive marker for targeted therapy
|
Duplications/ deletions of 17p13 (TP53 gene), 13q14 (RB1/DLEU/MIR15A-region), 11q22 (ATM, trisomy 12) | MLPA | 5-7 ml. of blood, with EDTA | 220 BGN | 15 working days |
| 187 |
Optimization of the therapy with the indirect anticoagulant acenocoumarol (Syntrome)
|
3 polymorphisms in CYP2C9 and VKORC1 genes (CYP2C92, CYP2C93, VKORC1-1639G>A) | HRM | 5-7 ml of blood, with EDTA | 100 BGN | 15 working days |
| 188 |
Optimization of platelet antiplatelet therapy clopidogrel (Plavix)
|
2 polymorphisms in CYP2C9 gene (CYP2C19*2, CYP2C19*17) | HRM | 5-7 ml of blood, with EDTA | 90 BGN | 15 working days |
| 189 |
Optimization of methotrexate therapy
|
5 polymorphic variants in MTHFR and ABCB1 genes | HRM | 5-7 ml of blood, with EDTA | 130 BGN | 15 working days |
| 190 |
Optimization of therapy with the anti-tuberculosis drug isoniazid in pulmonary tuberculosis
|
7 polymorphisms in NAT2 gene | Direct Sequencing | 5-7 ml of blood, with EDTA | 160 BGN | 15 working days |
| 191 |
Investigation of DPYD variants to optimize chemotherapy with 5-fluorouracil and capecitabine
|
Variants DPYD∗2A, DPYD∗13, c.2846A>T, and c.1236G>A. | Direct Sequencing | 5-7 ml of blood, with EDTA | 200 BGN | 15 working days |
| 192 |
Minimal residual disease in patients with neuroblastoma
|
Panel of two (TH and PHOX2B) expression markers in patients with Neuroblastoma | RT- PCR | 2-4 ml blood, with EDTA ; 1 ml bone narrow biopsy | 300 BGN | 15 working days |
| 193 |
Optimizing therapy with drugs from the thiopurine group (Azathioprine, Mercaptopurine and Thioguanine)
|
17 variants in the gene TPMT (TPMT *2, TPMT *3A, TPMT *3B, TPMT *3C, TPMT *3D, TPMT *4, TPMT* 6, TPMT *8, TPMT *9, TPMT*10, TPMT *11, TPMT *12, TPMT *13, TPMT *16, TPMT *17, TPMT *18, TPMT *24) | Direct Sequencing | 5-7 ml of blood, with EDTA | 240 BGN | 15 working days |
| 194 | 18 variants in NUDT15 gene (NUDT15 *2, NUDT15 *3, NUDT15*4, NUDT15*5, NUDT15*6, NUDT15*7, NUDT15*8, NUDT15*9, NUDT15*10, NUDT15*11-NUDT15*19) | Direct Sequencing | 5-7 ml of blood, with EDTA | 170 BGN | 15 working days | |
| 195 |
Slow metabolizers by CYP2C9
|
CYP2C9*2 ( rs1799853, c.430C>T) CYP2C9*3(rs1057910,c.1075A>C) | Direct Sequencing | 5-7 ml of blood, with EDTA | 100 BGN | 15 working days |
| 196 |
Slow metabolizers by CYP2C19
|
CYP2C19*2 ( rs4244285, c.681 G>A) CYP2C19*3 ( rs4986893, c.636G > A) | Direct Sequencing | 5-7 ml of blood, with EDTA | 100 BGN | 15 working days |
| 197 |
Slow metabolizers by CYP2D6
|
CYP2D6*3 ( rs35742686, 2550 Del A) CYP2D6*4 ( rs3892097, 1846G > A) | Direct Sequencing | 5-7 ml of blood, with EDTA | 140 BGN | 15 working days |
| 198 |
Diagnostic markers in brain, rhabdoid, solid and other tumors
|
Mutations in SMARCB1 gene | Direct Sequencing | 5-7 ml of blood, with EDTA/ Tumor tissue - FFPE or fresh frozen | 160 BGN | 30 working days |
| 199 | Deletions/duplications in region 22q11.21-q12.2, including TBX1, DGCR8, SNAP29, LZTR1, PPIL2, GNAZ, SMARCB1(INI1), SNRPD3, SEZ6L, NIPSNAP1 genes | MLPA | 5-7 ml of blood, with EDTA / Tumor tissue - FFPE or fresh frozen | 220 BGN | 30 working days | |
|
Next generation sequencing - Panels
|
||||||
| 200 |
Extended gene panel analysis for familial oncological diseases and interpretation
|
Mutations in 233 genes associated with oncology diseases | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1400 BGN | 50 working days |
| 201 |
Whole Exome Sequencing (WES) and interpretation of the clinical exome
|
Mutations in 5227 genes associated with hereditary diseases | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1600 BGN | 50 working days |
| 202 |
Whole Exome Sequencing (WES) without analysis and interpretation
|
Sequencing of 19 396 RefSeq genes. Read depth: mean coverage >= 50X, guaranteed 85% of bases with quality score >=Q30 | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 1200 BGN | 40 working days |
|
Carrier Testing
|
||||||
| 203 |
Carrier testing in a family with a known genetic cause of hereditary disease
|
Analysis of SINGLE gene mutation in 1 relative | Direct Sequencing | 5-7 ml of blood, with EDTA | 90 BGN | 7 working days |
| 204 |
Confirmation analysis of Next Generation Sequencing Gene Mutation (NGS)
|
Confirmation Analysis of SINGLE Gene mutation after Next Generation Sequencing (NGS) | Direct Sequencing | 5-7 ml of blood, with EDTA | 110 BGN | 7 working days |
| 205 |
Потвърдителен анализ /сегрегация на CNV вариант открит след секвениране от следващо поколение (NGS)
|
Конкретни Делеции/дупликации,пренареждания в различни части на генома, открити при секвениране от ново поколение (NGS) с микрочип | Chromosomal Microarray Analysis (аCGH) | 5-7 мл кръв, с EDTA | 1000 лв. / 511.29 EUR | 15 работни дни |
| 206 |
Потвърдителен анализ /сегрегация на аберации, открити чрез микрочипов анализ и NGS
|
Делеции/дупликации пренареждания в известни геномни райони | MLPA | 5-7 мл кръв, с EDTA | 300 лв. / 153.39 EUR | 15 работни дни |
| 207 |
Потвърдителен анализ /сегрегация на CNV вариант открит след секвениране от следващо поколение (NGS)
|
Делеции/дупликации пренареждания в известни геномни райони | RT- PCR | 5-7 мл кръв, с EDTA | 150 лв. / 76.69 EUR | 20 работни дни |
|
Microarray analysis
|
||||||
| 208 |
Microdeletion / microduplication syndromes
|
Microarray analysis with SurePrint G3 Unrestricted CGH 4x180K, ISCA v2 | Chromosomal Microarray Analysis (аCGH) | DNA | 1200 BGN | 15 working days |
| 209 |
Neurodevelopmental disorders/Autism spectrum disorders
|
Microarray analysis with SurePrint G3 Unrestricted CGH 4x180K, ISCA v2 | Chromosomal Microarray Analysis (аCGH) | DNA | 1200 BGN | 15 working days |
| 210 |
Congenital anomalies and malformative syndromes / miscarriages
|
Microarray analysis with Unrestricted HD-CGH array ISCA v2, 4x44K | Chromosomal Microarray Analysis (аCGH) | DNA | 1100 BGN | 15 working days |
|
Genomic Imprinting Syndromes
|
||||||
| 211 |
Prader Willi/Angelman syndromes
|
Large deletions/ insertions and rearrangements and methylation profile in genome region 15q11- PWS/AS | MS-MLPA | DNA | 260 BGN | 15 working days |
| 212 |
Russell-Silver/Beckwith-Wiedemann syndromes
|
Large deletions/ insertions and rearrangements and methylation profile in genome region 11p15BWS/RSS | MS-MLPA | DNA | 260 BGN | 15 working days |
| 213 |
Angelman syndromes
|
Mutations in UBE3A gene (exons 8-17) | Direct Sequencing | DNA | 220 BGN | 30 working days |
| 214 |
Изследване на унипарентна дизомия
|
Хромозоми 14 и 7, с метилационен MLPA | MS-MLPA | ДНК | 300 лв. / 153.39 EUR | 15 работни дни |
|
DNA Banking
|
||||||
| 215 |
DNA banking
|
DNA extraction of 1-3 ml blood | DNA Extraction by Magnetic Separation | 1-3 ml of blood, with EDTA | 20 BGN | 2 working days |
| 216 | DNA extraction of 4-6 ml blood | DNA Extraction by Magnetic Separation | 4-6 ml of blood, with EDTA | 35 BGN | 2 working days | |
| 217 | DNA extraction of 7-10 ml blood | DNA Extraction by Magnetic Separation | 7-10 ml of blood, with EDTA | 40 BGN | 2 working days | |
| 218 | DNA extracion and storage from fresh/frozen tissue | DNA Extraction by Column Method | tumor tissue/normal tissue | 25 BGN | 2 working days | |
| 219 | DNA extracion and storage from FFPE | DNA Extraction by Column Method | FFPE | 25 BGN | 3 working days | |
| 220 | DNA extracion and storage from 1 ml saliva | DNA Extraction by Column Method | saliva | 15 BGN | 2 working days | |
|
Services by request
|
||||||
| 221 |
Sequencing at the customer's request
|
1 fragment up to 700 bases with customer'sprimers | Direct Sequencing | DNA | 30 BGN | 5 working days |
| 222 | 24 fragments up to 700 bases with customer's primers | Direct Sequencing | DNA | 340 BGN | 5 working days | |
| 223 | 96 fragments up to 700 bases with customer's primers | Direct Sequencing | DNA | 1200 BGN | 7 working days | |
| 224 |
Fragment analysis at the customer's request
|
1 sample for 1 microsatellite marker and customer's primers | Fragment Analysis | DNA | 30 BGN | 5 working days |
| 225 | 1 sample for 24 microsatellites marker and customer's primers | Fragment Analysis | DNA | 210 BGN | 5 working days | |
| 226 | 1 sample for 96 microsatellite markers and customer's primers | Fragment Analysis | DNA | 800 BGN | 6 working days | |
| 227 |
Microarray scanning at the customer's request
|
1 microarray | Agilent скенер G2565CA, Feature Extraction | microarray | 20 BGN | 1 working days |
| 228 |
Microarray scanning and bioinformatics analysis at the customer's request
|
1 microarray | Agilent скенер G2565CA, Feature Extraction | microarray | 50 BGN | 1 working days |
| 229 |
Comprehensive bioinformatics analysis and interpretation of NGS data
|
Gene panel of 5 227 genes, associated with inhereted diseases | VarSeq Software | .bam files | 600 BGN | 40 working days |
| 230 | Whole exome - 19 396 RefSeq genes. Read depth - average coverage >=50X, guaranteed >= 85%bases with quality score >=Q30 | VarSeq Software | .fastq .bam .bed .vcf files | 800 BGN | 40 working days | |
| 231 |
Genetic counseling, Professor
|
Clinical interpretation and result, prepared and signed by a medical genetics specialist | Other | 80 BGN | ||
| 232 |
Genetic counseling, Medical doctor
|
Clinical interpretation and result, prepared and signed by a medical genetics specialist | Other | 60 BGN | ||
|
Services With Reagents Provided by Ministry of Health
|
||||||
| 233 |
Microarray analysis with reagents provided by the Ministry of Health
|
1 patient | Chromosomal Microarray Analysis (аCGH) | 5-7 ml of blood, with EDTA | 220 BGN | 15 working days |
| 234 |
Clinical exome analysis, confirmation and interpretation, with reagents provided by the Ministry of Health
|
1 patient | Clinical Exome Sequencing | 5-7 ml of blood, with EDTA | 850 BGN | 50 working days |
| 235 |
Цялостно геномно секвениране с анализ и интерпретация
|
1 пациент | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1200 лв. / 613.55 EUR | 60 работни дни |
| 236 |
Congenital adrenal hyperplasia (21 hydroxylase deficiency)
|
Mutations in CYP21A2 gene | Direct Sequencing, MLPA | 5-7 ml of blood, with EDTA | 500 BGN | 30 working days |
| 237 |
Neurofibromatosis type 1
|
Analysis of the NF1 gene for large deletions / insertions and rearrangements | MLPA | 5-7 ml of blood, with EDTA | 150 BGN | 15 working days |
| 238 |
Neurofibromatosis type 2
|
Analysis of the NF2 gene for large deletions / insertions and rearrangements | MLPA | 5-7 ml of blood, with EDTA | 180 BGN | 15 working days |
| 239 |
Growth deficiency
|
Analysis of the IGF1R gene for large deletions / amplifications | MLPA | 5-7 ml. of blood, with EDTA | 150 BGN | 15 working days |
| 240 |
Chromosomal copy number changes in childhood solid tumors (Neublastoma / rhabdomyosarcoma / Ewing's sarcoma / Wilm's tumor) with reagents provided by the Ministry of Health
|
MYCN Amplification Study, Chromosome Aberrations 1, 2, 3, 4, 7, 9, 11, 12, 14, 17 | MLPA | Tumor tissue - FFPE or fresh frozen | 150 BGN | 15 working days |
| 241 |
Детски солидни тумори
|
Анализ и интерпретация на соматични варианти в панел от гени, свързани с детски солидни тумори | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 400 лв. / 204.52 EUR | 40 работни дни |
|
Цялостно геномно секвениране (WGS)
|
||||||
| 242 |
Цялостно геномно секвениране с анализ и интерпретация на панел от до 100 гени
|
Секвениране на >20 000 RefSeq ядрени гени, включително SNVs, InDels,SVs, CNVs. Дълбочина на четене: средно покритие ≥30X, гарантирани ≥ 97% на бази с качество ≥Q10; анализ и интерпретация на панел от до 100 гени, свързани с конкретното заболяване | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 1900 лв. / 971.45 EUR | 40 работни дни |
| 243 |
Цялостно геномно секвениране с анализ и интерпретация на панел от 100 до 200 гени
|
Секвениране на >20 000 RefSeq ядрени гени, включително SNVs, InDels,SVs, CNVs. Дълбочина на четене: средно покритие ≥30X, гарантирани ≥ 97% на бази с качество ≥Q10; анализ и интерпретация на панел от 100 до 200 гени, свързани с конкретното заболяване | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 2100 лв. / 1073.71 EUR | 50 работни дни |
| 244 |
Цялостно геномно секвениране с анализ и интерпретация на панел от 200 до 500 гени
|
Секвениране на >20 000 RefSeq ядрени гени,включително SNVs, InDels,SVs, CNVs. Дълбочина на четене: средно покритие ≥30X, гарантирани ≥ 97% на бази с качество ≥Q10; анализ и интерпретация на панел от 200 до 500 гени, свързани с конкретното заболяване | Clinical Exome Sequencing | 5-7 мл кръв, с EDTA | 2300 лв. / 1175.97 EUR | 50 работни дни |
| 245 |
Цялостно геномно секвениране и анализ и интерпретация на панел от над 500 гени
|
Clinical Exome Sequencing | Секвениране на >20 000 RefSeq ядрени гени, включително SNVs, InDels,SVs, CNVs. Дълбочина на четене: средно покритие ≥30X, гарантирани ≥ 97% на бази с качество ≥Q10; анализ и интерпретация на панел от над 500 гени, свързани с конкретното заболяване | 2500 лв. / 1278.23 EUR | 50 работни дни | |
| 246 |
Биоинформатичен анализ и интерпретация на данни от Цялостно геномно секвениране (WGS)
|
Анализ и интерпретация на данни от Цялостно геномно секвениране (WGS), включващ екзомен панел от всички известни гени, асоциирани с наследствени заболявания | VarSeq Software | fatsq/bam/vcf (файлове) | 900 лв. / 460.16 EUR | 40 работни дни |
| 247 | Анализ и интерпретация на данни от Цялостно геномно секвениране (WGS), включващ SNVs, InDels,SVs, CNVs, асоциирани с наследствени заболявания | VarSeq Software | fatsq/bam/vcf (файлове) | 1200 лв. / 613.55 EUR | 40 работни дни | |